Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

A neurotensin analog blocks cocaine-conditioned place preference and reinstatement.

Boules M, Netz R, Fredrickson PA, Richelson E.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):236-9. doi: 10.1097/FBP.0000000000000227.

PMID:
26901162
2.

Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.

Boules MM, Fredrickson P, Muehlmann AM, Richelson E.

Behav Sci (Basel). 2014 Jun 13;4(2):125-53. doi: 10.3390/bs4020125. eCollection 2014 Jun. Review.

3.

Neurotensin agonist attenuates nicotine potentiation to cocaine sensitization.

Fredrickson P, Boules M, Stennett B, Richelson E.

Behav Sci (Basel). 2014 Jan 22;4(1):42-52. doi: 10.3390/bs4010042. eCollection 2014 Mar.

4.

Diverse roles of neurotensin agonists in the central nervous system.

Boules M, Li Z, Smith K, Fredrickson P, Richelson E.

Front Endocrinol (Lausanne). 2013 Mar 22;4:36. doi: 10.3389/fendo.2013.00036. eCollection 2013.

5.

NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.

Smith KE, Boules M, Williams K, Richelson E.

Behav Brain Res. 2012 Jun 15;232(1):93-7. doi: 10.1016/j.bbr.2012.03.044. Epub 2012 Apr 5.

PMID:
22504145
6.

The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.

Smith KE, Boules M, Williams K, Fauq AH, Richelson E.

Behav Brain Res. 2011 Oct 31;224(2):344-9. doi: 10.1016/j.bbr.2011.06.014. Epub 2011 Jun 21.

7.

Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.

Boules M, Johnston H, Tozy J, Smith K, Li Z, Richelson E.

Behav Pharmacol. 2011 Sep;22(5-6):573-81. doi: 10.1097/FBP.0b013e3283474a3a.

PMID:
21691202
8.

Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.

Oliveros A, Heckman MG, Del Pilar Corena-McLeod M, Williams K, Boules M, Richelson E.

J Exp Biol. 2010 Dec 15;213(Pt 24):4232-9. doi: 10.1242/jeb.046318.

9.

A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats.

Boules M, Oliveros A, Liang Y, Williams K, Shaw A, Robinson J, Fredrickson P, Richelson E.

Neuropeptides. 2011 Feb;45(1):9-16. doi: 10.1016/j.npep.2010.09.003. Epub 2010 Nov 2.

PMID:
21047685
10.

NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse.

Li Z, Boules M, Richelson E.

Neurosci Lett. 2011 Jan 10;487(3):322-4. doi: 10.1016/j.neulet.2010.10.048. Epub 2010 Oct 23.

PMID:
20974215
11.

Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.

Li Z, Boules M, Williams K, Gordillo A, Li S, Richelson E.

Neurobiol Dis. 2010 Nov;40(2):467-77. doi: 10.1016/j.nbd.2010.07.011. Epub 2010 Jul 24.

12.

Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.

Liang Y, Boules M, Li Z, Williams K, Miura T, Oliveros A, Richelson E.

Neuropharmacology. 2010 Jun;58(8):1199-205. doi: 10.1016/j.neuropharm.2010.02.015. Epub 2010 Mar 6.

13.
14.

The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.

Li Z, Boules M, Williams K, Peris J, Richelson E.

Brain Res. 2010 Jan 22;1311:28-36. doi: 10.1016/j.brainres.2009.11.048. Epub 2009 Nov 27.

15.

NT79: A novel neurotensin analog with selective behavioral effects.

Boules M, Liang Y, Briody S, Miura T, Fauq I, Oliveros A, Wilson M, Khaniyev S, Williams K, Li Z, Qi Y, Katovich M, Richelson E.

Brain Res. 2010 Jan 13;1308:35-46. doi: 10.1016/j.brainres.2009.10.050. Epub 2009 Oct 27.

16.

Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.

Briody S, Boules M, Oliveros A, Fauq I, Richelson E.

Behav Brain Res. 2010 Feb 11;207(1):118-24. doi: 10.1016/j.bbr.2009.09.044. Epub 2009 Oct 2.

17.

Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).

Liang Y, Shaw AM, Boules M, Briody S, Robinson J, Oliveros A, Blazar E, Williams K, Zhang Y, Carlier PR, Richelson E.

J Pharmacol Exp Ther. 2008 Nov;327(2):573-83. doi: 10.1124/jpet.108.143610. Epub 2008 Aug 8.

PMID:
18689611
18.

Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.

Liang Y, Boules M, Shaw AM, Williams K, Fredrickson P, Richelson E.

Brain Res. 2008 Sep 22;1231:6-15. doi: 10.1016/j.brainres.2008.07.037. Epub 2008 Jul 19.

PMID:
18687313
19.

Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression.

Corena-McLeod Mdel P, Oliveros A, Charlesworth C, Madden B, Liang YQ, Boules M, Shaw A, Williams K, Richelson E.

Brain Res. 2008 Oct 3;1233:8-19. doi: 10.1016/j.brainres.2008.07.021. Epub 2008 Jul 15.

PMID:
18657526
20.

Neurotensin agonists: potential in the treatment of schizophrenia.

Boules M, Shaw A, Fredrickson P, Richelson E.

CNS Drugs. 2007;21(1):13-23. Review.

PMID:
17190526

Supplemental Content

Loading ...
Support Center